Are hydrocortisone ointment and bacitracin appropriate for treating acute or chronic paronychia?

Hydrocortisone Ointment is Appropriate, Bacitracin is Not

For chronic paronychia, topical corticosteroids like hydrocortisone are highly effective and should be the primary treatment, while bacitracin and other antibiotics are largely ineffective and not recommended. For acute paronychia, neither is typically appropriate as first-line therapy.

Treatment Approach by Type

Chronic Paronychia

Topical corticosteroids are the evidence-based treatment of choice. Multiple high-quality studies demonstrate that topical steroids significantly outperform systemic antifungals and antibiotics 1. In a randomized controlled trial, methylprednisolone aceponate achieved improvement or cure in 85% of treated nails compared to only 53% with terbinafine and 45% with itraconazole 1. More recent data from 2026 confirms that corticosteroid-based therapy led to improvement in 90.7% of cases, with 38.1% achieving complete or near-complete resolution, while first-line antifungal/antibiotic therapy was ineffective in 76.3% of patients 2.

Why hydrocortisone works: Chronic paronychia is fundamentally an inflammatory condition triggered by irritants and allergens, not primarily an infectious process 3, 1. The presence of Candida is often coincidental colonization rather than causative - Candida eradication was associated with clinical cure in only 2 of 18 patients who carried Candida at baseline 1.

Why bacitracin doesn't work: Antibiotics and antifungals target microorganisms that are not the primary pathogenic drivers of chronic paronychia 2, 1, 4. The condition results from repeated inflammation leading to fibrosis of the proximal nail fold with poor cuticle generation 4.

Critical Treatment Components for Chronic Paronychia:

• Apply topical corticosteroid (hydrocortisone 1% or stronger formulations like betamethasone or tacrolimus 0.1%) twice daily for 3-4 months 2, 5
• Hand-care modifications are mandatory and significantly impact outcomes (P<0.01) 2:
  • Minimize prolonged contact with liquids
  • Wear non-powdered waterproof gloves for wet tasks
  • Use mild fragrance-free cleansers
  • Apply moisturizer after each handwashing
• Treatment duration matters: Longer treatment (mean 4 months) correlates with better outcomes (P<0.05) 2
• Adherence is critical: Regular topical application significantly predicts success (P<0.001) 2

Acute Paronychia

For acute paronychia, neither hydrocortisone nor bacitracin is typically first-line therapy 3. Acute paronychia results from direct trauma allowing pathogen inoculation and requires:

• Warm compresses for early/mild cases
• Incision and drainage for purulent collections
• Oral antibiotics (amoxicillin-clavulanic acid) only for complicated cases with cellulitis 6
• Postoperative antibiotics do not influence recurrence in uncomplicated cases 6

Common Pitfalls to Avoid

1. Don't treat chronic paronychia as a fungal infection - this leads to prolonged ineffective antifungal therapy when corticosteroids would work 1
2. Don't use antibiotics for chronic paronychia - they are ineffective for this inflammatory condition 2, 3
3. Don't prescribe topical therapy without emphasizing hand-care modifications - behavioral changes are as important as medication 2
4. Don't stop treatment too early - chronic paronychia requires 3-4 months of consistent therapy 2

Strength of Evidence

The recommendation for topical corticosteroids over antibiotics/antifungals in chronic paronychia is supported by:

• Multiple randomized controlled trials 1, 5
• Recent large retrospective study (97 patients, 2026) 2
• Consistent findings across multiple research groups 3, 4

Tacrolimus 0.1% may be superior to betamethasone with cure rates of 93% vs. 57% 5, though hydrocortisone 1% remains a reasonable first-line option given its safety profile and OTC availability 7.